Vascular calcification burden of Chinese patients with chronic kidney disease: methodology of a cohort study

Zhi-Hong Liu1,

  • 1National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, 305 East Zhong Shan Road, Nanjing, 210016, China. liuzhihong@nju.edu.cn.

BMC Nephrology
|August 5, 2015
PubMed

Insights

This study investigates vascular calcification prevalence in Chinese patients with end-stage renal disease (ESRD). Findings will inform clinical decisions for dialysis patients, addressing a critical knowledge gap in China.

Area of Science:

  • Nephrology
  • Cardiology
  • Public Health

Background:

  • Vascular calcification is a frequent complication in chronic kidney disease (CKD).
  • It is a primary driver of cardiovascular disease (CVD) in end-stage renal disease (ESRD) patients.
  • The prevalence and impact of vascular calcification in China remain largely uncharacterized.

Purpose of the Study:

  • To determine the prevalence of vascular calcification in Chinese patients with stage 5 CKD on dialysis.
  • To assess the predictive value of vascular calcification for mortality and cardiovascular events.
  • To survey disease management practices and their influence on vascular calcification.

Main Methods:

  • National, multicenter, prospective cohort study.
  • Recruitment of 1520 ESRD patients on hemodialysis or peritoneal dialysis across 24 centers in China.
  • 24-month follow-up with imaging for vascular, coronary artery, abdominal aortic, and cardiac valve calcification.

Main Results:

  • Prevalence of vascular calcification, coronary artery calcification, abdominal aortic calcification, and cardiac valve calcification will be determined.
  • Association between vascular calcification and all-cause/cardiovascular mortality and non-fatal cardiovascular events will be analyzed.
  • Impact of disease management (serum calcium, phosphorus, PTH levels) on vascular calcification will be surveyed.

Conclusions:

  • This study will provide crucial data on vascular calcification in Chinese dialysis patients.
  • Results will enhance clinical decision-making for managing CKD complications.
  • Findings aim to reduce the burden of cardiovascular disease in this high-risk population.
Abstract

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
627
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.2K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
970
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
308
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
864
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
1.6K